Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Unisys
UIS
$207M
| $9.78M | 0.02% |
1,269,864
+649,574
| +105% | +$6.18M |
|
1152
Orion
OEC
$366M
| $9.77M | 0.02% |
691,698
+185,698
| +37% | +$2.34M |
|
|
ASEI
1153
DELISTED
AMER SCIENCE & ENGR INC.
ASEI
| $9.76M | 0.02% |
352,600
+58,900
| +20% | +$1.76M |
|
1154
RLJ Lodging Trust
RLJ
$1.69B
| $9.74M | 0.02% |
425,800
-561,600
| -57% | -$11.3M |
|
|
MASI
1155
DELISTED
Masimo
MASI
| $9.74M | 0.02% |
232,700
+10,300
| +5% | +$387K |
|
|
FCH
1156
DELISTED
Felcor Lodging Trust
FCH
| $9.74M | 0.02% |
1,199,000
-590,500
| -33% | -$4.23M |
|
1157
Huntsman Corp
HUN
$1.82B
| $9.73M | 0.02% |
731,700
-378,900
| -34% | -$3.91M |
|
|
TMH
1158
DELISTED
Team Health Holdings Inc
TMH
| $9.71M | 0.02% |
232,300
+210,000
| +942% | +$8.59M |
|
|
MENT
1159
DELISTED
Mentor Graphics Corp
MENT
| $9.7M | 0.02% |
+477,098
| New | +$8.71M |
|
1160
Haemonetics
HAE
$4.14B
| $9.7M | 0.02% |
277,200
+87,500
| +46% | +$2.83M |
|
|
PTLA
1161
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $9.69M | 0.02% |
474,800
+335,700
| +241% | +$10.7M |
|
|
HTB
1162
HomeTrust Bancshares
HTB
$837M
| $9.68M | 0.02% |
527,815
-10,400
| -2% | -$190K |
|
1163
TTEC Holdings
TTEC
$80.8M
| $9.64M | 0.02% |
347,200
+38,800
| +13% | +$1.04M |
|
|
FBC
1164
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $9.64M | 0.02% |
449,100
-42,077
| -9% | -$843K |
|
1165
A10 Networks
ATEN
$1.96B
| $9.6M | 0.02% |
1,622,290
+435,590
| +37% | +$2.6M |
|
1166
Safety Insurance
SAFT
$1.52B
| $9.57M | 0.02% |
167,686
+19,986
| +14% | +$1.11M |
|
|
NXGN
1167
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $9.57M | 0.02% |
627,700
+89,000
| +17% | +$1.35M |
|
1168
G-III Apparel Group
GIII
$1.42B
| $9.56M | 0.02% |
195,600
-148,100
| -43% | -$7.17M |
|
|
MYCC
1169
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $9.56M | 0.02% |
680,822
+205,922
| +43% | +$2.72M |
|
|
MDVN
1170
DELISTED
MEDIVATION, INC.
MDVN
| $9.54M | 0.02% |
+207,600
| New | +$7.53M |
|
|
HIMX
1171
Himax Technologies
HIMX
$2.59B
| $9.52M | 0.02% |
846,961
-256,325
| -23% | -$2.25M |
|
|
MNTA
1172
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $9.51M | 0.02% |
1,029,051
+478,465
| +87% | +$5.15M |
|
1173
RB Global
RBA
$15.7B
| $9.49M | 0.02% |
350,400
+248,056
| +242% | +$5.86M |
|
|
FPRX
1174
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $9.48M | 0.02% |
233,300
-79,900
| -26% | -$2.75M |
|
|
STOR
1175
DELISTED
STORE Capital Corporation
STOR
| $9.47M | 0.02% |
+365,900
| New | +$8.97M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.